Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profiles.
Ye W. et al, (2021), Br J Cancer, 124, 1661 - 1669
Activated Regulatory T-Cells, Dysfunctional and Senescent T-Cells Hinder the Immunity in Pancreatic Cancer
SIVAKUMAR S. et al, (2021), Molecular Biomarkers and Precision Medicine for Pancreatic, Liver and Biliary Tract Cancers
Long-term real-world experience with ipilimumab and non-ipilimumab therapies in advanced melanoma: the IMAGE study
Dalle S. et al, (2021), BMC Cancer
Long-term real-world experience with ipilimumab and non-ipilimumab therapies in advanced melanoma: the IMAGE study
Dalle S. et al, (2021), BMC Cancer
Tumour gene expression signature in primary melanoma predicts long-term outcomes
Garg M. et al, (2021), Nature Communications
Tebentafusp, A TCR/Anti-CD3 Bispecific Fusion Protein Targeting gp100, Potently Activated Antitumor Immune Responses in Patients with Metastatic Melanoma.
Middleton MR. et al, (2020), Clin Cancer Res, 26, 5869 - 5878
Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial.
Ascierto PA. et al, (2020), Lancet Oncol, 21, 1465 - 1477
sFRP2 Supersedes VEGF as an Age-related Driver of Angiogenesis in Melanoma, Affecting Response to Anti-VEGF Therapy in Older Patients.
Fane ME. et al, (2020), Clin Cancer Res, 26, 5709 - 5719
Intratumoural immunotherapies for unresectable and metastatic melanoma: current status and future perspectives.
Middleton MR. et al, (2020), Br J Cancer, 123, 885 - 897
Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?
Cheung VTF. et al, (2020), Br J Cancer, 123, 207 - 215
ctDNA monitoring using patient-specific sequencing and integration of variant reads.
Wan JCM. et al, (2020), Sci Transl Med, 12
Indirect treatment comparison of nivolumab versus placebo for the adjuvant treatment of melanoma.
Hemstock M. et al, (2020), Eur J Cancer, 132, 176 - 186
Tuning transcription factor availability through acetylation-mediated genomic redistribution
GODING C., (2020), Molecular Cell
Comment on 'Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines'.
Peris K. et al, (2020), Eur J Cancer, 131, 100 - 103
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention.
Stratigos AJ. et al, (2020), Eur J Cancer, 128, 60 - 82
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment.
Stratigos AJ. et al, (2020), Eur J Cancer, 128, 83 - 102
Pharmacodynamic effect of tebentafusp (TCR-CD3 bispecific) on peripheral cytokines and association with overall survival in patients with advanced melanoma
Middleton MR. et al, (2020), JOURNAL OF TRANSLATIONAL MEDICINE, 18
Relationship between clinical efficacy and AEs of tebentafusp, a novel bispecific TCR-anti-CD3, in patients with advanced melanoma
Middleton MR. et al, (2020), JOURNAL OF TRANSLATIONAL MEDICINE, 18